The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients ...

Heading north from the Chizuruya General Store and going east to the rice fields, you'll come across a Hokora just before the fields. Opposite the Hokora, the Ema is tucked away behind a small straw ...

Harpreet Singh, MD, former Director of the Division of Oncology 2 at the FDA, noted the importance of considering the global regulatory environment in the development of radiopharmaceuticals. This is ...